prefinal Flashcards

1
Q

These are events or circumstances involving drug therapy that actually or potentially interfere with desired health outcomes.

A

Medication-related problems (MRPs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The patient has a medical condition that requires medication but is not receiving appropriate treatment.

A

Untreated Indications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The prescribed medication is not the most appropriate choice for the patient’s condition.

A

Improper Drug Selection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The prescribed dosage is too low to achieve the desired therapeutic effect.

A

Subtherapeutic Dosage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The prescribed dosage is too high, increasing the risk of adverse effects.

A

Overdosage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The patient does not receive the prescribed medication.

A

Failure to receive medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

An unintended, undesirable, and often harmful effect of a medication.

A

Adverse Drug Reaction (ADR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The interaction between two or more drugs that can alter the efficacy or safety of one or both drugs.

A

Drug Interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A patient is taking a medication for which there is no medical need.

A

Drug Use Without Indication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Immature organ systems, dosing challenges

A

Age (Pediatrics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Polypharmacy, altered pharmacokinetics, cognitive impairment

A

Age (Geriatrics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hormonal differences affecting drug metabolism and response

A

Gender

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Genetic polymorphisms influencing drug metabolism and response

A

Genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Multiple chronic conditions increasing the risk of drug interactions and adverse
effects

A

Comorbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lack of understanding, forgetfulness, or intentional non-adherence

A

Non-Adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Incorrect dosage, frequency, or duration of therapy

A

Prescribing Error

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Failure to consider drug interactions or contraindications

A

Prescribing Error

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Poor communication between healthcare providers

A

Communication error

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Inadequate Patient Education

A

Communication error

20
Q

Insufficient understanding of drug therapy guidelines and evidence-based
practices

A

Lack of Knowledge

21
Q

It refers to the use of multiple medications by a patient, typically defined as the regular use of five or more medications.

A

Polypharmacy

22
Q

Increased risk of drug interactions and adverse effects

A

Polypharmacy

23
Q

Difficult to remember and manage

A

Complex Drug Regimen

24
Q

Pharmacokinetic and pharmacodynamic interactions

A

Drug Interactions

25
Q

Pharmacokinetic and pharmacodynamic interactions

A

Drug Interactions

26
Q

Unintended side effects of medications

A

Adverse Drug Reactions (ADRs)

27
Q

Lack of communication between healthcare providers

A

Poorly Coordinated Care

28
Q

Difficulty accessing healthcare services, especially in rural or underserved areas

A

Limited Access to Care

29
Q

High cost of medications, leading to non-adherence

A

Economic Factors

30
Q

Disruptions in medication supply and potential for therapeutic failures

A

Medication Shortages

31
Q

It is any undesirable or harmful effect that occurs after the administration of a medication at normal doses used for prophylaxis, diagnosis, or therapy.

A

Adverse Drug Reaction (ADR)

32
Q

Key Characteristics of ADRs:

A
  1. Unintended and Harmful Effects
  2. Dose-Related or Non-Dose-Related
  3. Time-Dependent
33
Q

ADRs can occur immediately after taking the drug or after prolonged use, and can range from immediate reactions (e.g., allergic reactions) to delayed reactions (e.g., drug-induced liver toxicity).

A

Time-Dependent

34
Q

They may occur with the usual dose or as a result of an overdose, but can also occur at therapeutic levels, depending on individual sensitivity.

A

Dose-Related or Non-Dose-Related

35
Q

ADRs are not part of the intended therapeutic action of the drug

A

Unintended and Harmful Effects

36
Q

These are dose-dependent reactions that are related to the pharmacological action of the drug.

A

Type A: Augmented

37
Q

This reactions are more predictable and are often associated with well-known side effects of the drug.

A

Type A: Augmented

38
Q

These are idiosyncratic, unpredictable, and not dose-dependent. They often result from the individual’s unique genetic or immune system factors, such as allergies or sensitivities.

A

Type B: Bizzare

39
Q

Related to long-term drug use or chronic exposure (e.g., corticosteroid-induced
osteoporosis & Chronic renal failure from long term use of NSAID).

A

Type C: Chronic

40
Q

Delayed adverse drug effects, carcinogenicity, teratogenicity (ex. Teratogenic effect of chemotherapeutic agent

A

Type D: Delayed

41
Q

Occurs after the drug is discontinued (e.g., withdrawal symptoms from benzodiazepines).

A

Type E: End-Of-Treatment

42
Q

Occurs when the drug fails to provide the expected therapeutic effect (e.g., drug resistance, such as with antibiotics).

A

Type F: Failure

43
Q

Factors Affecting ADRs

A
  • Patient-related factors (age, genetics, comorbidities)
  • Drug-related factors (dosage, route of administration, formulation)
  • Environmental factors (temperature, humidity)
44
Q

The science and activities relating to the detection, assessment, understanding,
and prevention of adverse effects or any other drug-related problem.

A

Pharmacovigilance

45
Q

intended pharmacological actions that are unwanted

A

side effects

46
Q

harmful effects that occur at higher than therapeutic doses or due to an individual’s vulnerability

A

toxicity